Shiga Microalbuminuria Reduction Trial-2

Summary

Shiga Microalbuminuria Reduction Trial-2 is a clinical trial^[1].

Key Facts

• Shiga Microalbuminuria Reduction Trial-2 is in the country of Japan^[2].
• Shiga Microalbuminuria Reduction Trial-2's instance of is recorded as clinical trial^[3].
• Shiga Microalbuminuria Reduction Trial-2's start time is recorded as +2011-10-31T00:00:00Z^[4].
• Shiga Microalbuminuria Reduction Trial-2's end time is recorded as +2014-08-31T00:00:00Z^[5].
• Shiga Microalbuminuria Reduction Trial-2's main subject is recorded as arterial hypertension^[6].
• Shiga Microalbuminuria Reduction Trial-2's main subject is recorded as diabetes^[7].
• Shiga Microalbuminuria Reduction Trial-2's number of participants is recorded as {'unit': '1', 'amount': '+237'}^[8].
• Shiga Microalbuminuria Reduction Trial-2's title is recorded as Clinical Investigation on the Effects of Reducing Microalbuminuria in Hypertensive Patients With Type 2 Diabetes - SMART2^[9].
• Shiga Microalbuminuria Reduction Trial-2's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+20'}^[10].
• Shiga Microalbuminuria Reduction Trial-2's ClinicalTrials.gov ID is recorded as NCT01461499^[11].
• Shiga Microalbuminuria Reduction Trial-2's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}^[12].
• Shiga Microalbuminuria Reduction Trial-2's research intervention is recorded as angiotensin receptor antagonist^[13].
• Shiga Microalbuminuria Reduction Trial-2's clinical trial phase is recorded as phase IV clinical trial^[14].
• Shiga Microalbuminuria Reduction Trial-2's research site is recorded as Shiraz University^[15].
• Shiga Microalbuminuria Reduction Trial-2's research subject recruitment status is recorded as completed^[16].
• Shiga Microalbuminuria Reduction Trial-2's study type is recorded as interventional study^[17].